2,4-Dichloro-5-fluorobenzoyl chloride | CAS:86393-34-2

We serve 2,4-Dichloro-5-fluorobenzoyl chloride CAS:86393-34-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,4-Dichloro-5-fluorobenzoyl chloride

CAS No: 86393-34-2
Product Name: 2,4-Dichloro-5-fluorobenzoyl chloride
Other Name:
2,4-Dichloro-5-fluorobenzoyl chloride
2,4-dichloro-5-fluoro-benzoyl chloride
2,4-dichloro-5-fluorobenzoic acid chloride
 
Density: 1.6±0.1 g/cm3
Boiling Point: 244.1±0.0 °C at 760 mmHg
Molecular Formula: C7H2Cl3FO
Molecular Weight: 227.448
Flash Point: 108.7±25.9 °C
Exact Mass: 225.915527
PSA: 17.07000
LogP: 3.47
Vapour Pressure: 0.0±0.4 mmHg at 25°C
Index of Refraction: 1.556
 
Specification
Appearance: Colorless To Pale Yellow Liquid
Assay: ≥98.0%
Loss on drying: ≤0.5%
 
Application
Intermediates of Ciprofloxacin CAS: 85721-33-1.
Be used as pharmaceutical intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like 2,4-Dichloro-5-fluorobenzoyl chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,4-dichloro-5-fluorobenzoic acid chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,4-dichloro-5-fluorobenzoic acid chloride Use and application,2,4-dichloro-5-fluorobenzoic acid chloride technical grade,usp/ep/jp grade.


Related News: Pharmaceutical intermediates and APIs belong to the fine chemical industry.(4-(1-Phenyl-1H-benzo[d]imidazol-2-yl)phenyl)boronic acid manufacturer Pharmaceutical intermediates and APIs belong to the fine chemical industry.2,3,4,5-Tetrafluorobenzoic acid supplier New Zealand citizens and permanent residents and their immediate family members will still be able to enter — but must self-isolate for 14 days after arriving back into the country.Bis(trimethoxysilylpropyl)amine vendor The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.The drug, Imfinzi, when added to chemotherapy and the drugmaker’s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said.